Literature DB >> 16502110

Binding and clearance of radioactive adrenaline and noradrenaline in sheep blood.

S M El-Bahr1, H Kahlbacher, M Patzl, R G Palme.   

Abstract

An understanding of the conditions influencing protein binding of catecholamines (CAs) is important in studying their metabolic effects. Unfortunately, reports on plasma protein binding of CAs are scarce, conflicting and mainly performed in vitro. The aim of our in vivo and in vitro studies was to investigate binding and clearance of radioactive adrenaline (epinephrine) ((3)H-A), noradrenaline (norepinephrine) ((3)H-NA) and their metabolites in sheep blood. The time course of the radioactivity in the blood after intravenous injection of (3)H-A and (3)H-NA (3.7 MBq each) in 4 sheep (2 of each sex; total of 8 administrations) was determined. Blood samples were taken from the jugular vein. The highest radioactivity was observed in the first sample (5 min) following injection. Radioactivity showed a biphasic disappearance. An initial stage, in which radioactivity decreased rapidly (within 1 h) after the injection, was followed by a slow stage, lasting for up to 1 month, until background levels were reached. In vitro results indicated that NA and A were present not only in plasma (70%) but also in the erythrocytes (30%; mainly bound to haemoglobin). Sephadex G-25 gel filtration revealed that from the plasma fraction about 15% was strongly bound to proteins (mainly albumin). These results demonstrate that previous experiments in this field have overestimated the percentage of CAs bound to plasma proteins, because binding to haemoglobin was previously not known. In the future, efforts should be made to characterize the adduct products of CAs and establish an assay to determine them in vivo. If this could be achieved, it would yield a valuable tool for measuring the stress experienced for a longer period.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16502110     DOI: 10.1007/s11259-006-3244-1

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  14 in total

1.  Relationships between structure and albumin-binding of amines tested with crossing-paper electrophoresis.

Authors:  M H BICKEL; D BOVET
Journal:  J Chromatogr       Date:  1962-08

2.  The physiological disposition of H3-epinephrine and its metabolite metanephrine.

Authors:  J AXELROD; H WEIL-MALHERBE; R TOMCHICK
Journal:  J Pharmacol Exp Ther       Date:  1959-12       Impact factor: 4.030

3.  Catecholamine binding protein: binding of tritium to a specific protein fraction of human plasma following in vitro incubation with tritiated noradrenaline.

Authors:  B L Mirkin; D M Brown; R A Ulstrom
Journal:  Nature       Date:  1966-12-10       Impact factor: 49.962

4.  Binding of catechol derivatives to human serum proteins.

Authors:  P May; F J Sanders; R K Donabedian
Journal:  Experientia       Date:  1974-03-15

5.  Binding of catecholamines to human serum albumin.

Authors:  A Danon; J D Sapira
Journal:  J Pharmacol Exp Ther       Date:  1972-08       Impact factor: 4.030

6.  In vitro binding study of epinephrine and bovine serum albumin.

Authors:  H Zia; R H Cox; L A Luzzi
Journal:  J Pharm Sci       Date:  1971-01       Impact factor: 3.534

7.  Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk).

Authors:  K T Khaw; N Wareham; R Luben; S Bingham; S Oakes; A Welch; N Day
Journal:  BMJ       Date:  2001-01-06

8.  Binding of adrenaline and isoprenaline to plasma proteins of the dog.

Authors:  F Teixeira; D Branco; J F Torrinha
Journal:  Pharmacology       Date:  1979       Impact factor: 2.547

9.  Plasma protein binding of catecholamines, prazosin and propranolol in diabetes mellitus.

Authors:  T S Trovik; R Jaeger; R Jorde; O Ingebretsen; G Sager
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

10.  A dopamine transporter in human erythrocytes: modulation by insulin.

Authors:  R Azoui; J L Cuche; J F Renaud; M Safar; G Dagher
Journal:  Exp Physiol       Date:  1996-05       Impact factor: 2.969

View more
  3 in total

Review 1.  Use of inotropes and vasopressor agents in critically ill patients.

Authors:  Mansoor N Bangash; Ming-Li Kong; Rupert M Pearse
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Advances in biochemical screening for phaeochromocytoma using biogenic amines.

Authors:  Malcolm J Whiting; Matthew P Doogue
Journal:  Clin Biochem Rev       Date:  2009-02

3.  Excretion of catecholamines in rats, mice and chicken.

Authors:  M Lepschy; S Rettenbacher; C Touma; R G Palme
Journal:  J Comp Physiol B       Date:  2008-02-15       Impact factor: 2.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.